368 related articles for article (PubMed ID: 29063289)
21. Sal synthase induced cytotoxicity of PC12 cells through production of the dopamine metabolites salsolinol and N-methyl-salsolinol.
Xiong Q; Zheng X; Wang J; Chen Z; Deng Y; Zhong R; Wang J; Chen X
J Integr Neurosci; 2022 Mar; 21(2):71. PubMed ID: 35364659
[TBL] [Abstract][Full Text] [Related]
22. (R)salsolinol N-methyltransferase activity increases in parkinsonian lymphocytes.
Naoi M; Maruyama W; Nakao N; Ibi T; Sahashi K; Benedetti MS
Ann Neurol; 1998 Feb; 43(2):212-6. PubMed ID: 9485062
[TBL] [Abstract][Full Text] [Related]
23. Cell death in Parkinson's disease.
Maruyama W; Naoi M
J Neurol; 2002 Sep; 249 Suppl 2():II6-10. PubMed ID: 12375057
[TBL] [Abstract][Full Text] [Related]
24. [Pathogenesis of idiopathic Parkinson's disease].
Maruyama W
Nihon Ronen Igakkai Zasshi; 2001 Jul; 38(4):494-7. PubMed ID: 11523160
[TBL] [Abstract][Full Text] [Related]
25. Possible steady-state concentrations of tetrahydroisoquinolines in brain after the consumption of ethanol.
Weiner H
Fed Proc; 1981 May; 40(7):2082-5. PubMed ID: 7227563
[TBL] [Abstract][Full Text] [Related]
26. N-methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity.
Maruyama W; Dostert P; Matsubara K; Naoi M
Free Radic Biol Med; 1995 Jul; 19(1):67-75. PubMed ID: 7635360
[TBL] [Abstract][Full Text] [Related]
27. Key role of salsolinol in ethanol actions on dopamine neuronal activity of the posterior ventral tegmental area.
Melis M; Carboni E; Caboni P; Acquas E
Addict Biol; 2015 Jan; 20(1):182-93. PubMed ID: 24103023
[TBL] [Abstract][Full Text] [Related]
28. Presence of methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, derivatives of the neurotoxin isoquinoline, in parkinsonian lumbar CSF.
Moser A; Kömpf D
Life Sci; 1992; 50(24):1885-91. PubMed ID: 1598074
[TBL] [Abstract][Full Text] [Related]
29. N-methyl(R)salsolinol and a neutral N-methyltransferase as pathogenic factors in Parkinson's disease.
Maruyama W; Strolin-Benedetti M; Naoi M
Neurobiology (Bp); 2000; 8(1):55-68. PubMed ID: 11008878
[TBL] [Abstract][Full Text] [Related]
30. Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains.
Niwa T; Takeda N; Yoshizumi H; Tatematsu A; Yoshida M; Dostert P; Naoi M; Nagatsu T
Biochem Biophys Res Commun; 1991 Jun; 177(2):603-9. PubMed ID: 2049084
[TBL] [Abstract][Full Text] [Related]
31. O-methylation of (+)-(R)- and (-)-(S)-6,7-dihydroxy-1-methyl-1,2,3,4-tetrahydroisoquinoline (salsolinol) in the presence of pig brain catechol-O-methyltransferase.
Hötzl BK; Thomas H
Chirality; 1997; 9(4):367-72. PubMed ID: 9275315
[TBL] [Abstract][Full Text] [Related]
32. An endogenous MPTP-like dopaminergic neurotoxin, N-methyl(R)salsolinol, in the cerebrospinal fluid decreases with progression of Parkinson's disease.
Maruyama W; Abe T; Tohgi H; Naoi M
Neurosci Lett; 1999 Feb; 262(1):13-6. PubMed ID: 10076861
[TBL] [Abstract][Full Text] [Related]
33. The role of salsolinol in alcohol intake and withdrawal.
Clow A; Topham A; Saunders JB; Murray R; Sandler M
Prog Clin Biol Res; 1985; 183():101-13. PubMed ID: 4048178
[TBL] [Abstract][Full Text] [Related]
34. Salsolinol, an endogenous compound triggers a two-phase opposing action in the central nervous system.
Możdżeń E; Kajta M; Wąsik A; Lenda T; Antkiewicz-Michaluk L
Neurotox Res; 2015 Apr; 27(3):300-13. PubMed ID: 25537852
[TBL] [Abstract][Full Text] [Related]
35. Endogenous synthesis of N-methylsalsolinol, an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in rat brain during in vivo microdialysis with salsolinol, as demonstrated by gas chromatography-mass spectrometry.
Niwa T; Maruyama W; Nakahara D; Takeda N; Yoshizumi H; Tatematsu A; Takahashi A; Dostert P; Naoi M; Nagatsu T
J Chromatogr; 1992 Jul; 578(1):109-15. PubMed ID: 1400775
[TBL] [Abstract][Full Text] [Related]
36. Local salsolinol modulates dopamine extracellular levels from rat nucleus accumbens: shell/core differences.
Hipólito L; Sánchez-Catalán MJ; Granero L; Polache A
Neurochem Int; 2009 Sep; 55(4):187-92. PubMed ID: 19524107
[TBL] [Abstract][Full Text] [Related]
37. Effect of acetaldehyde on urinary salsolinol in healthy man after ethanol intake.
Adachi J; Mizoi Y; Fukunaga T; Kogame M; Ninomiya I; Naito T
Alcohol; 1986; 3(3):215-20. PubMed ID: 3741618
[TBL] [Abstract][Full Text] [Related]
38. Isolation of salsolinol, a tetrahydroisoquinoline alkaloid, from the marine sponge Xestospongia cf. vansoesti as a proteasome inhibitor.
Nagasawa Y; Ueoka R; Yamanokuchi R; Horiuchi N; Ikeda T; Rotinsulu H; Mangindaan RE; Ukai K; Kobayashi H; Namikoshi M; Hirota H; Yokosawa H; Tsukamoto S
Chem Pharm Bull (Tokyo); 2011; 59(2):287-90. PubMed ID: 21297314
[TBL] [Abstract][Full Text] [Related]
39. Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: advantage of a new high-performance liquid chromatography methodology.
Antkiewicz-Michaluk L; Krygowska-Wajs A; Szczudlik A; Romańska I; Vetulani J
Biol Psychiatry; 1997 Sep; 42(6):514-8. PubMed ID: 9285087
[TBL] [Abstract][Full Text] [Related]
40. Dopamine-derived tetrahydroisoquinolines and Parkinson's disease.
Dostert P; Strolin Benedetti M; Della Vedova F; Allievi C; La Croix R; Dordain G; Vernay D; Durif F
Adv Neurol; 1993; 60():218-23. PubMed ID: 8420138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
